三联联合疗法中断后血浆和细胞内HIV载量的高反弹 - Suppr

Suppr

超能文献

High rebound of plasma and cellular HIV load after discontinuation of triple combination therapy.

作者信息

Jubault V, Burgard M, Le Corfec E, Costagliola D, Rouzioux C, Viard J P

出版信息

AIDS. 1998 Dec 3;12(17):2358-9.

PMID:9863885

Abstract

摘要

相似文献

High rebound of plasma and cellular HIV load after discontinuation of triple combination therapy.

AIDS. 1998 Dec 3;12(17):2358-9.

Early increase in cell-associated HIV-1 DNA in patients on highly active antiretroviral therapy.

AIDS. 1998 Dec 24;12(18):2500-2.

Immunologic and virologic response of HIV-2 infection to antiretroviral therapy.

AIDS. 1998 Dec 24;12(18):2506-7.

Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4+ T-cell counts <200 cells/mm3: 96-week outcomes.

Antivir Ther. 2005;10(8):911-6.

Using ritonavir with indinavir in cases of virologic failure.

TreatmentUpdate. 2001 Spring;12(12):7.

AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.

AIDS. 2000 Mar 10;14(4):367-74.

[Antiretroviral therapy in patients infected with HIV-1].

Medicina (B Aires). 1998;58 Suppl 1:49-56.

Antivir Ther. 2004 Dec;9(6):979-85.

Stavudine, lamivudine plus novel protease inhibitor therapy in antiretroviral-naive HIV-infected individuals treated for 24 weeks.

Antivir Ther. 1999;4 Suppl 3:85-7.

Vaccination and HIV-1 replication during highly active antiretroviral therapy.

AIDS. 1999 Jan 14;13(1):135-6.

引用本文的文献

The role of Nef in the long-term persistence of the replication-competent HIV reservoir in South African women.

J Virol. 2025 Jun 24:e0021725. doi: 10.1128/jvi.00217-25.

The role of Nef in the long-term persistence of the replication-competent HIV reservoir in South African women.

bioRxiv. 2024 Nov 3:2024.11.01.621615. doi: 10.1101/2024.11.01.621615.

Sequence Analysis of Inducible, Replication-Competent Virus Reveals No Evidence of HIV-1 Evolution During Suppressive Antiviral Therapy, Indicating a Lack of Ongoing Viral Replication.

Open Forum Infect Dis. 2024 Apr 17;11(5):ofae212. doi: 10.1093/ofid/ofae212. eCollection 2024 May.

The timing of HIV-1 infection of cells that persist on therapy is not strongly influenced by replication competency or cellular tropism of the provirus.

PLoS Pathog. 2024 Feb 29;20(2):e1011974. doi: 10.1371/journal.ppat.1011974. eCollection 2024 Feb.

Can HIV Be Cured and Should We Try?

Mayo Clin Proc. 2015 Jun;90(6):705-9. doi: 10.1016/j.mayocp.2015.03.008. Epub 2015 May 2.

A more precise HIV integration assay designed to detect small differences finds lower levels of integrated DNA in HAART treated patients.

Virology. 2008 Sep 15;379(1):78-86. doi: 10.1016/j.virol.2008.05.030. Epub 2008 Jul 22.

Immunotherapy with canarypox vaccine and interleukin-2 for HIV-1 infection: termination of a randomized trial.

PLoS Clin Trials. 2007 Jan 26;2(1):e5. doi: 10.1371/journal.pctr.0020005.

Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha.

J Exp Med. 2003 Jul 21;198(2):361-7. doi: 10.1084/jem.20021924.

Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects.

Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13288-93. doi: 10.1073/pnas.221452198. Epub 2001 Oct 30.

HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy.

J Clin Invest. 1999 Sep;104(6):R13-8. doi: 10.1172/JCI7371.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验